Morgan Stanley has maintained its ‘underweight’ rating on Crompton Greaves Consumer Electricals stock with a target price of ₹352, citing a cautious outlook despite the company’s strategic focus on premiumisation and technological advancements. Crompton recently launched two advanced platforms, Nucleus and Xtech, aimed at strengthening its fans portfolio and expanding its share in the premium segment.
The Nucleus platform is an advanced BLDC (Brushless Direct Current) platform, while Xtech is an advanced induction motor platform, both designed to enhance product efficiency and performance. Morgan Stanley noted that premium fans are growing at approximately 2 times the average fan market growth rate, and Crompton is targeting to increase premiumisation share to 40% of its overall portfolio.
Yesterday’s stock price performance:
On February 27, Crompton Greaves’ share price closed at ₹322.75, down by ₹8.75 or 2.64%. The decline reflects investor caution, aligning with Morgan Stanley’s cautious outlook despite the company’s strategic focus on premiumisation and new technology launches.
Disclaimer: The views and investment tips expressed by investment experts on Business Upturn are their own and not those of the website or its management. Business Upturn advises users to check with certified experts before taking any investment decisions.
